antibiotic withdrawal
PreclinicalSmall molecule
antibiotic withdrawal is one of 6 small molecule programs targeting Pleural Infection. It is currently in Preclinical.
2
Indications
2
Total Trials
1
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
5 competitors in Antibiotic Therapy
#DrugCompanyPhaseTrials
1Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 1
Rifampicin
Boehringer IngelheimPreclinical
Azithromycin Pill
RRambam Health Care Campus
Preclinical
antibiotic withdrawal
CCentre Hospitalier Universitaire, Amiens
Preclinical
Bordetella Pertussis B1917
UUniversity of Southampton
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Antibiotic Therapy1 trial
Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection
Recruiting·—·N/A·NCT07030673·256 enrolled
Pleural Infection1 trial
Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections
Completed·—·N/A·NCT04350502·11 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for antibiotic withdrawal. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details